Single Use Ophthalmic Surgical Devices Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

The single-use ophthalmic surgical devices market covers disposable instruments, consumables, and associated products used in eye surgeries including cataract extraction, glaucoma intervention, retinal repair, and refractive procedures. Valued at roughly $12.53 billion in 2025, the market is expected to reach approximately $16.84 billion by 2031, expanding at a CAGR of 5.06% over the forecast period. This segment sits within the broader ophthalmology surgical devices ecosystem and benefits from the same macroeconomic and demographic tailwinds, while the disposability preference adds a recurring revenue characteristic as each procedure requires fresh single-use components.

• •Market valued at ~$12.53 billion in 2025, reaching ~$13.16 billion in 2026 and ~$16.84 billion by 2031
• •CAGR of 5.06% projected for the 2026-2031 forecast period
• •Catheter and cataract surgery devices represented roughly 41% of the broader ophthalmic surgical devices market in 2025

The primary growth engine is the worldwide increase in age-related ocular disorders, particularly cataracts and glaucoma, which require surgical intervention and rely heavily on single-use instrumentation. Expanding healthcare infrastructure across Asia Pacific and other emerging regions, combined with rising healthcare expenditures and improving reimbursement frameworks, is widening the pool of patients able to access surgical care. The rapid adoption of ambulatory surgical centers in North America and comparable outpatient settings globally further accelerates demand, as these facilities are purpose-built for high-volume procedures that consume large volumes of disposable devices.

• •Global aging demographics driving sustained demand for cataract and glaucoma surgical procedures
• •Expansion of ambulatory surgical centers and outpatient facilities favoring single-use consumables for infection control
• •Favorable reimbursement adjustments and rising healthcare spending in emerging economies unlocking new patient access

By procedure type, cataract surgery devices dominate the market, capturing over 41% of the broader ophthalmic surgical devices share in 2025. Glaucoma surgery devices represent the fastest-growing subsegment, forecast to expand at an 8.63% CAGR, outpacing the overall market as minimally invasive glaucoma treatments gain clinical traction. Geographically, North America leads in market value due to advanced healthcare infrastructure and widespread ASC adoption, while Asia Pacific is the fastest-expanding region, fueled by improving access to low-cost platforms and growing surgical volumes in China, India, and Southeast Asia.

• •Cataract surgery devices held ~41.02% of market share in 2025; glaucoma devices projected at 8.63% CAGR
• •North America leads in value driven by ASC adoption and favorable reimbursement; Asia Pacific is the fastest-growing region
• •Low-cost purpose-built platforms in Asia Pacific are widening access and accelerating procedure volumes

Who are the notable companies in the industry?

The market exhibits a moderately consolidated structure, with a handful of established manufacturers controlling significant share through integrated product portfolios that span diagnostics, planning software, and surgical instruments. Competitive differentiation increasingly rests on the ability to offer connected digital ecosystems rather than standalone disposable products, as manufacturers bundle software-driven planning and image guidance with hardware. Production capacity is concentrated in regions with mature medical device manufacturing infrastructure, particularly in North America, Western Europe, and parts of East Asia, though contract manufacturing and supply chain diversification are gradually shifting some capacity toward Southeast Asia and Eastern Europe.

• •Market shows moderate consolidation with integrated producers offering combined hardware, software, and consumable ecosystems
• •Competitive positioning increasingly tied to digital workflow integration rather than individual disposable devices
• •Manufacturing and supply chain capacity concentrated in North America, Western Europe, and East Asia with gradual diversification

What are the recent trends and outlook?

Product innovation is concentrated in phacoemulsification systems, image-guided surgical microscopes, and minimally invasive glaucoma implants, all of which are designed to improve clinical outcomes while increasing surgeon throughput. The integration of diagnostics, surgical planning, and intraoperative navigation into unified digital workflows is a defining trend, enabling premium product differentiation and creating stickier customer relationships. Over the forecast horizon, the combined effect of aging populations, expanding global surgical coverage, and continued ASC proliferation positions the market for steady, above-moderate growth, with glaucoma and minimally invasive segments offering the most pronounced upside relative to the broader category.

• •Phaco systems, image-guided microscopes, and minimally invasive glaucoma implants are key innovation frontiers
• •Integrated digital ecosystems combining diagnostics, planning, and surgery are becoming a primary differentiation lever
• •Glaucoma and minimally invasive subsegments are expected to outperform the broader market over the 2026-2031 forecast period